Live Breaking News & Updates on பார்மா வைத்திருத்தல்|Page 2
Stay updated with breaking news from பார்மா வைத்திருத்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders. ....
318.7 1 There is no dilution effect for potential ordinary shares for periods where earnings have been negative. 2 Alternative performance measure (APM). Defined on page 20 in the interim report. CEO Comments The first quarter of 2021 has been very productive for Vicore continuing to build on the clinical success achieved with C21 in 2020. In the beginning of February, the company raised 336 MSEK (approx. 40 MUSD) in a directed share issue that attracted Swedish and international institutional investors, including existing shareholders. The strengthened financial position allows Vicore to fund operations well into 2023. The fundraising followed results of Vicore s phase II COVID-19 trial ATTRACT. The data, published on the online preprint server medRxiv at the beginning of January, showed that C21, Vicore s angiotensin type 2 receptor agonist, spares the need for oxygen supplementation and clearly restores respiratory function in hospitalized COVID-19 pat ....
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF - Webinar will be held today at 15:00 CET (9:00 am EST) - Digital therapeutics expert Jessica Shull joins Vicore to drive DTx program News provided by Share this article GOTHENBURG, Sweden, May 4, 2021 /PRNewswire/ Vicore Pharma Holding AB (publ) ( Vicore ), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis (IPF), today announces the signing of an agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx Platform . Vicore will hold a webinar at 15:00 CET (9 AM EST) today to outline the strategic importance and operational details of the new program. ....
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.